Martine Neyens
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Viral Dynamic Model-Informed Dose Selection of Mosnodenvir Prophylaxis against DENV-3 in a Controlled Human Infection Model.
Journal: Clinical pharmacology and therapeutics
Published: April 02, 2026
Population pharmacokinetics and pharmacodynamics of canagliflozin in paediatric patients with type 2 diabetes mellitus.
Journal: British journal of clinical pharmacology
Published: October 22, 2025
Nipocalimab Dose Selection in Generalized Myasthenia Gravis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 31, 2025
Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).
Journal: European journal of drug metabolism and pharmacokinetics
Published: April 28, 2024
Model-Informed Clinical Development of Once-Every-6-Month Injection of Paliperidone Palmitate in Patients with Schizophrenia: A Pharmacometric Bridging Approach (Part I).
Journal: European journal of drug metabolism and pharmacokinetics
Published: April 28, 2024
Mechanistic modeling projections of antibody persistence after homologous booster regimens of COVID-19 vaccine Ad26.COV2.S in humans.
Journal: CPT: pharmacometrics & systems pharmacology
Published: June 21, 2023
Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach.
Journal: Clinical pharmacology and therapeutics
Published: July 18, 2022
Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Journal: The Journal of antimicrobial chemotherapy
Published: January 26, 2021
Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia.
Journal: Clinical pharmacology in drug development
Published: March 01, 2019
Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial.
Journal: Pharmaceutical research
Published: November 06, 2018
Population Pharmacokinetic Modeling of Canagliflozin in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus.
Journal: Clinical pharmacokinetics
Published: August 22, 2015
The method of averaging applied to pharmacokinetic/pharmacodynamic indirect response models.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: November 19, 2014
Last Updated: 09/26/2026